Question 1

What is the catalog number for RIPK1-IN-22?

Accepted Answer

The catalog number for RIPK1-IN-22 is orb3133850.

Question 2

What sizes are available for RIPK1-IN-22?

Accepted Answer

RIPK1-IN-22 is available in the following size(s): 50 mg, 10 mg.

Question 3

How many pack sizes does RIPK1-IN-22 come in?

Accepted Answer

RIPK1-IN-22 is available in 2 different pack sizes.

Question 4

Is RIPK1-IN-22 in stock?

Accepted Answer

RIPK1-IN-22 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is RIPK1-IN-22 used for?

Accepted Answer

RIPK1-IN-13 (compound 28) is a selective inhibitor of receptor-interacting serine/threonine-protein kinase 1 (RIPK1), showing a pKi of 7.66 as measured by the ADP-Glo kinase assay. It exhibits inhibitory effects in human leukemia U937 cells with a pIC50 of 7.2.

Question 6

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 7

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 8

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

RIPK1-IN-22

Product Specifications

Field of Research

Molecular Formula

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Lanicemine-d5

PAX8 (Renal Cell Marker) (PAX8/1491), CF488A conjugate, 0.1mg/mL

1-(2-Phenylethyl)piperazine

Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/1564R), CF405S conjugate, 0.1mg/mL

1,2-Benzisoxazol-3-ylacetic Acid

3’,4’-Dihydroxy-1-phenyl-2-butanone